These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28419761)

  • 1. Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanercept.
    Haridas V; Shetty P; Dsouza LC; Dinesh US; Haridas K; Bargale A
    Int J Rheum Dis; 2017 May; 20(5):657-659. PubMed ID: 28419761
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum: intractable leg ulcers in Sjogren's syndrome.
    Tsai YH; Huang CT; Chai CY; Wu CC
    Kaohsiung J Med Sci; 2014 Sep; 30(9):486-8. PubMed ID: 25224774
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlooked.
    Khattri S; Barland P
    Bull NYU Hosp Jt Dis; 2012; 70(2):130-2. PubMed ID: 22892005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary Sjögren's syndrome revealing cerebellar syndrome].
    Meriglier E; Debouverie O; Walter-Lepage A; Brigaud A; Beuvon C; Luca L
    Rev Neurol (Paris); 2015 Sep; 171(8-9):674-6. PubMed ID: 25912281
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of sensorineural hearing loss in Sjögren's syndrome with corticosteroid.
    Kim KS; Kim HS
    Korean J Intern Med; 2016 May; 31(3):612-5. PubMed ID: 27055663
    [No Abstract]   [Full Text] [Related]  

  • 6. Sjögren's syndrome presenting with isolated sensory axonal polyneuropathy.
    Di Lazzaro V; Rigon A; Soriano A; Capone F; Corbetto M; Florio L; Afeltra A; Onetti Muda A; Luigetti M
    Int J Rheum Dis; 2017 Dec; 20(12):2165-2167. PubMed ID: 27453550
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome.
    Hervier B; Lambert M; Hachulla E; Musset L; Benveniste O; Piette JC; Amoura Z; Costedoat-Chalumeau N
    Rheumatology (Oxford); 2011 Jun; 50(6):1175-6. PubMed ID: 21454309
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum and annular erythema associated with Sjögren's syndrome controlled with minocycline.
    Yamanaka K; Murota H; Goto H; Yamamoto S; Katayama I; Taniguchi Y; Mizutani H
    J Dermatol; 2015 Aug; 42(8):834-6. PubMed ID: 25899670
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Sjögren's syndrome complicated by anti-neutrophil cytoplasmic antibody-mediated crescentic glomerulonephritis.
    Ghorbel IB; Belfeki N; Salem TB; Houman MH
    Saudi J Kidney Dis Transpl; 2017; 28(5):1184-1187. PubMed ID: 28937084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Biologics in Sjögren's Syndrome.
    Nocturne G; Cornec D; Seror R; Mariette X
    Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of large refractory pyoderma gangrenosum-like presentation of granulomatosis with polyangiitis by rituximab.
    Sen M; Dogra S; Rathi M; Sharma A
    Int J Rheum Dis; 2017 Dec; 20(12):2200-2202. PubMed ID: 27126548
    [No Abstract]   [Full Text] [Related]  

  • 12. Sjögren syndrome in a child: favorable response of the arthritis to TNFalpha blockade.
    Pessler F; Monash B; Rettig P; Forbes B; Kreiger PA; Cron RQ
    Clin Rheumatol; 2006 Sep; 25(5):746-8. PubMed ID: 16391885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome.
    Baldini C; Notarstefano C; Pepe P; Ferro F; Luciano N; Tani C; Talarico R; Mosca M
    Clin Exp Rheumatol; 2013; 31(1):160. PubMed ID: 23021087
    [No Abstract]   [Full Text] [Related]  

  • 14. Annular erythema associated with Sjögren's syndrome preceding overlap syndrome of rheumatoid arthritis and polymyositis with anti-PL-12 autoantibodies.
    Sugiura K; Muro Y; Akiyama M
    Acta Derm Venereol; 2014 Jul; 94(4):470-1. PubMed ID: 24322624
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of pyoderma gangrenosum with etanercept.
    McGowan JW; Johnson CA; Lynn A
    J Drugs Dermatol; 2004; 3(4):441-4. PubMed ID: 15303791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.
    Del Giacco SR; Firinu D; Lorrai MM; Serusi L; Meleddu R; Barca MP; Peralta M; Manconi PE
    Acta Derm Venereol; 2012 Jul; 92(4):439-40. PubMed ID: 22392509
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of Sjögren's syndrome with acute transverse myelitis and polyneuropathy in a patient free of sicca symptoms.
    Tristano AG
    Clin Rheumatol; 2006 Feb; 25(1):113-4. PubMed ID: 15980937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic polyangiitis associated with primary biliary cirrhosis, Sjogren's syndrome and Hashimoto's thyroiditis.
    Ghorbel IB; Belfeki N; Salem TB; Hamzaoui A; Khanfir M; Lamloum M; Miled M; Houman MH
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):359-62. PubMed ID: 25758890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiphospholipid antibody-positive Sjögren's syndrome with leg ulcers.
    Ota S; Muro Y; Kono M; Goto N; Akiyama M
    J Dermatol; 2019 Nov; 46(11):e429-e430. PubMed ID: 31321801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.